Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial)

https://doi.org/10.1016/0002-9149(93)90637-RGet rights and content

Abstract

To determine the effect of thrombolytic therapy on the frequency of right ventricular (RV) dysfunction, and whether RV dysfunction is a risk factor for morbidity and mortality after discharge from the hospital, 1,110 patients in the Thrombolysis in Myocardial Infarction (TIMI) II trial with acute inferior wall left ventricular myocardial infarction were studied. RV dysfunction was defined as an RV wall motion abnormality on equilibrium radionuclide ventriculography performed a mean of 9 days after admission to the hospital. Fifty-eight patients (5%) had RV dysfunction. Baseline clinical characteristics among patients with and without RV dysfunction were similar. However, patients with RV dysfunction had a lower mean left ventricular ejection fraction (51.2 ± 1.2% vs 55.5 ± 0.3%; p < 0.001) and a greater frequency of inhospital complications. Angiographic data from patients undergoing protocol catheterization 18 to 48 hours after hospital admission show that the infarct-related artery was more likely to be occluded in those with RV dysfunction (48% [15 of 31] vs 14% [68 of 495]; p < 0.001). There was no difference in the frequency of multivessel disease between the 2 groups. In patients with RV dysfunction in whom radionuclide ventriculography was repeated 6 weeks after hospital discharge, RV wall motion abnormalities persisted in only 18% (8 of 45). Mortality in the year after discharge was 3.5% (2 of 58) among patients with RV dysfunction compared with 1.7% (18 of 1,052; p = NS) among those without RV dysfunction. Thus, RV dysfunction occurs infrequently after thrombolytic therapy, particularly in patients with patency of the infarct-related artery 18 to 24 hours after such therapy. Among surviving patients who undergo predischarge radionuclide ventriculography, RV dysfunction is not associated with a significantly increased mortality in the year after discharge from the hospital.

References (25)

  • N Gadsboll et al.

    Right and left ventricular ejection fractions: relation to one-year prognosis in acute myocardial infarction

    Eur Heart J

    (1987)
  • Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial

    N Engl J Med

    (1989)
  • Cited by (89)

    • Management of Post–Myocardial Infarction Right Ventricular Failure

      2023, Journal of the Society for Cardiovascular Angiography and Interventions
    • Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction

      2022, International Journal of Cardiology
      Citation Excerpt :

      Previous studies examining the prognostic impact of RVMI on patients with acute inferior MI just involved a small number of patients with very few outcome events. Of importance, these patients were mostly treated by thrombolysis therapy [3,5,14]. With recent development in reperfusion strategy, especially primary PCI, it is unclear whether the prognosis of inferior STEMI patients with RVMI has changed.

    • Right ventricular infarction

      2018, Cardiac Intensive Care
    • Right ventricular infarction

      2018, Cardiovascular Revascularization Medicine
      Citation Excerpt :

      The effectiveness of reperfusion in patients with RVI and infero-posterior MI has been less impressive than in patients with anterior wall MI [35]. Some studies suggest that RV function recovers only after successful reperfusion [68–70] whereas others report improvement even in the absence of a patent infarct-related vessel [71,72]. Study by Zehender et al. [73] found that both mortality and major in-hospital complications were lower in patients who received thrombolytics than in those who did not.

    • Right-Sided Heart Disorders

      2017, Textbook of Clinical Hemodynamics, Second Edition
    View all citing articles on Scopus

    This study was supported in part by Grant NO1-HV-38031 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.

    View full text